National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 70974 [06-9573]
Download as PDF
<![CDATA[
70974
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate proposals for
support through the RAID program by
making available to the research
community, on a competitive basis, NCI
new agent development contract
resources for the preclinical
development of drugs and biologics.
The outcome of the evaluation will be
a decision whether NCI should support
the request and make available contract
resources for support through the RAID
program to the research community,
NCI new agent development for the
preclinical development of drugs and
biologics. The research proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
sroberts on PROD1PC70 with NOTICES
Name of Committee: National Cancer
Institute Special Emphasis Panel Rapid
Access to Intervention Development.
Date: December 20, 2006.
Time: 8:30 a.m.–5 p.m.
Agenda: To evaluate Rapid Access to
Intervention Development Portfolio.
Place: National Institutes of Health, 6130
Executive Boulevard, Rm. 319, Rockville, MD
20852.
Contact Person: Phyllis G. Bryant,
Executive Secretary, Program Analyst,
Developmental Therapeutics Program,
National Cancer Institute, NIH, 6130
Executive Boulevard, Rm. 8022, Bethesda,
MD 20892, 301 435–9137.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: November 30, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9577 Filed 12–6–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
17:29 Dec 06, 2006
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
National Institutes of Health
Dated: December 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9573 Filed 12–6–06; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Demonstration and Education Research
Grants.
Date: December 15, 2006.
Time: 9 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Patricia A. Haggerty, PhD,
Scientific Review Administrator, National
Heart, Lung, and Blood Institute/NIH,
Clinical Studies & Training Studies Rev.
Grp., Division of Extramural Affairs/Section
Chief, 6701 Rockledge Drive, Room 7194,
Bethesda, MD 20892, 301/435–0288,
haggertp@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Coronary Intervention Trial.
Date: December 19, 2006.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: William J. Johnson, PhD,
Scientific Review Administrator, Review
Branch, Division of Extramural Research
Activities, NIH/NHLBI, 6701 Rockledge
Drive, Bethesda, MD 20892–7924, 301–435–
0317, johnsonw@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee Group
A.
Date: January 5, 2007.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Jerry Roberts, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Institutes of Health,
Building 38A, Bethesda, MD 20892, 301 402–
0838.
Name of Committee: Center for Inherited
Disease Research Access Committee Group B.
Date: January 5, 2007.
Time: 3:15 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Rudy Pozzatti, PhD,
Scientific Review Administrator, Scientific
Review Branch, National Human Genome
Research Institute, 5635 Fishers Lane, Suite
4076, MSC 9306, Bethesda, MD 20852, (301)
402–0838, pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
E:\FR\FM\07DEN1.SGM
07DEN1
]]>Agencies
[Federal Register Volume 71, Number 235 (Thursday, December 7, 2006)]
[Notices]
[Page 70974]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9573]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Demonstration and Education Research Grants.
Date: December 15, 2006.
Time: 9 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Patricia A. Haggerty, PhD, Scientific Review
Administrator, National Heart, Lung, and Blood Institute/NIH,
Clinical Studies & Training Studies Rev. Grp., Division of
Extramural Affairs/Section Chief, 6701 Rockledge Drive, Room 7194,
Bethesda, MD 20892, 301/435-0288, haggertp@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Coronary Intervention Trial.
Date: December 19, 2006.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: William J. Johnson, PhD, Scientific Review
Administrator, Review Branch, Division of Extramural Research
Activities, NIH/NHLBI, 6701 Rockledge Drive, Bethesda, MD 20892-
7924, 301-435-0317, johnsonw@nhlbi.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: December 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9573 Filed 12-6-06; 8:45 am]
BILLING CODE 4140-01-M
